CLDI · Forms 3, 4, 5
Insider trades at Calidi Biotherapeutics, Inc.
No open-market insider buys or sells at Calidi Biotherapeutics, Inc. in the last 90 days; 8 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Calidi Biotherapeutics, Inc. (CLDI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| George Peoples | Director | Options or other derivatives | Form 4 | ||||
| Scott Leftwich | Director | Options or other derivatives | Form 4 | ||||
| Alan R. Stewart | Director | Options or other derivatives | Form 4 | ||||
| Andrew C. Jackson | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| James A Schoeneck | Director | Options or other derivatives | Form 4 | ||||
| Eric E Poma | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Santidrian Antonio Fernandez | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Sanders Corazon (Corsee) D. | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.